InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Browse the detailed record of transactions filed by Nanavaty Maulik, Vice-Président Senior. Director active across 2 companies, notably Boston Scientific CORP. In total, 11 disclosures have been recorded. Split: 0 buy · 2 sells. Total volume traded: €5.5m. Activity tracked since 28 May 2021. The latest transaction was filed on 28 February 2022 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Declarations11 total
1,630 shares0Common StockSEC:0001225208-22-003865:0
1,714 shares0Common StockSEC:0001225208-22-003085:0
2,166 shares0Common StockSEC:0001225208-22-002924:0
1,661 shares0Common StockSEC:0001225208-22-002681:0
1,661 shares0Common StockSEC:0001225208-22-002681
11,017 shares0Class A Common StockSEC:0001209191-22-007638:0
11,017 shares0Class A Common StockSEC:0001209191-22-007638
6,175 shares0Common StockSEC:0001225208-22-000115:0
6,175 shares0Common StockSEC:0001225208-22-000115
78,192 shares@ US$42.59310.0019% mcap100.0% of flowCommon StockSEC:0001225208-21-008788
78,192 shares@ US$42.59310.0019% mcap50.0% of flowCommon StockSEC:0001225208-21-008788:0
11 of 11 declarations
About Nanavaty Maulik
Maulik Nanavaty is Senior Vice President and President, Neuromodulation at BOSTON SCIENTIFIC CORP and Board Member at Rani Therapeutics Holdings, Inc. He is responsible for leading neuromodulation initiatives within the company.
